Stegent Equity Advisors Inc. Acquires 487 Shares of The Clorox Company (NYSE:CLX)

Stegent Equity Advisors Inc. grew its stake in The Clorox Company (NYSE:CLX) by 29.8% in the third quarter, Holdings Channel.com reports. The institutional investor owned 2,123 shares of the company’s stock after buying an additional 487 shares during the quarter. Stegent Equity Advisors Inc.’s holdings in Clorox were worth $346,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of Clorox by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock valued at $2,339,150,000 after buying an additional 48,632 shares in the last quarter. Nuance Investments LLC boosted its stake in shares of Clorox by 150.6% in the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after purchasing an additional 960,094 shares in the last quarter. Van ECK Associates Corp raised its position in Clorox by 1,715.5% in the 2nd quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock worth $199,411,000 after purchasing an additional 1,380,724 shares during the period. Bank of New York Mellon Corp lifted its stake in Clorox by 14.4% in the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock worth $131,200,000 after purchasing an additional 120,716 shares during the last quarter. Finally, Acadian Asset Management LLC grew its stake in shares of Clorox by 26.5% during the first quarter. Acadian Asset Management LLC now owns 882,526 shares of the company’s stock valued at $135,099,000 after buying an additional 184,847 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analyst Ratings Changes

CLX has been the topic of several recent research reports. Barclays raised their price target on Clorox from $130.00 to $137.00 and gave the stock an “underweight” rating in a research report on Friday, October 11th. DA Davidson reaffirmed a “neutral” rating and issued a $153.00 target price on shares of Clorox in a research note on Friday, September 6th. TD Cowen began coverage on shares of Clorox in a research report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target for the company. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Finally, Evercore ISI cut their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. Six equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $150.14.

Clorox Stock Down 0.4 %

Shares of NYSE CLX traded down $0.65 during mid-day trading on Friday, hitting $161.96. 682,801 shares of the stock traded hands, compared to its average volume of 1,230,643. The company has a market cap of $20.11 billion, a price-to-earnings ratio of 83.92, a PEG ratio of 3.19 and a beta of 0.41. The stock has a fifty day moving average price of $159.28 and a 200-day moving average price of $145.15. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.09. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Research analysts anticipate that The Clorox Company will post 6.64 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.01%. Clorox’s dividend payout ratio is currently 252.85%.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.51% of the stock is currently owned by company insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.